A Rare Case of Renal Recovery in a Young Patient with Multiple Myeloma

Overview

Journal Case Rep Nephrol

Publisher Wiley

Specialty Nephrology

Date 2014 Feb 22

PMID 24558623

Authors

Hasan J Salameh

Adeel Ahmad

Tina Kochar

Affiliations

Soon will be listed here.

Abstract

Multiple myeloma (MM) is an uncommon hematologic malignancy accounting for 1% of all malignancies. Renal involvement is a common complication of MM. Rapid intervention to reverse renal dysfunction may be critical for management, especially in patients with light chain cast nephropathy. Recovery rate ranges from 5% to 15%. We describe an atypical presentation of MM in a young patient who presented with severe renal insufficiency requiring renal replacement therapy and achieved complete renal recovery with chemotherapy.

References

Rayner H, Haynes A, Thompson J, Russell N, Fletcher J . Perspectives in multiple myeloma: survival, prognostic factors and disease complications in a single centre between 1975 and 1988. Q J Med. 1991; 79(290):517-25. View

Blade J, Fernandez-Llama P, Bosch F, Montoliu J, Lens X, Montoto S . Renal failure in multiple myeloma: presenting features and predictors of outcome in 94 patients from a single institution. Arch Intern Med. 1998; 158(17):1889-93. DOI: 10.1001/archinte.158.17.1889. View

Blade J, Kyle R, Greipp P . Presenting features and prognosis in 72 patients with multiple myeloma who were younger than 40 years. Br J Haematol. 1996; 93(2):345-51. DOI: 10.1046/j.1365-2141.1996.5191061.x. View

Blade J, Kyle R . Multiple myeloma in young patients: clinical presentation and treatment approach. Leuk Lymphoma. 1998; 30(5-6):493-501. DOI: 10.3109/10428199809057562. View

Knudsen L, Hippe E, Hjorth M, Holmberg E, Westin J . Renal function in newly diagnosed multiple myeloma--a demographic study of 1353 patients. The Nordic Myeloma Study Group. Eur J Haematol. 1994; 53(4):207-12. DOI: 10.1111/j.1600-0609.1994.tb00190.x. View

Jain M, Ascensao J, Schechter G . Familial myeloma and monoclonal gammopathy: a report of eight African American families. Am J Hematol. 2008; 84(1):34-8. DOI: 10.1002/ajh.21325. View

Kyle R, Gertz M, Witzig T, Lust J, Lacy M, Dispenzieri A . Review of 1027 patients with newly diagnosed multiple myeloma. Mayo Clin Proc. 2003; 78(1):21-33. DOI: 10.4065/78.1.21. View

Corso A, Klersy C, Lazzarino M, Bernasconi C . Multiple myeloma in younger patients: the role of age as prognostic factor. Ann Hematol. 1998; 76(2):67-72. DOI: 10.1007/s002770050365. View

Phekoo K, Schey S, Richards M, Bevan D, Bell S, Gillett D . A population study to define the incidence and survival of multiple myeloma in a National Health Service Region in UK. Br J Haematol. 2004; 127(3):299-304. DOI: 10.1111/j.1365-2141.2004.05207.x. View

10.

Ludwig H, Durie B, Bolejack V, Turesson I, Kyle R, Blade J . Myeloma in patients younger than age 50 years presents with more favorable features and shows better survival: an analysis of 10 549 patients from the International Myeloma Working Group. Blood. 2008; 111(8):4039-47. PMC: 4259800. DOI: 10.1182/blood-2007-03-081018. View

11.

Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun M . Cancer statistics, 2009. CA Cancer J Clin. 2009; 59(4):225-49. DOI: 10.3322/caac.20006. View

12.

Huang S, Yao M, Tang J, Lee W, Tsay W, Cheng A . Epidemiology of multiple myeloma in Taiwan: increasing incidence for the past 25 years and higher prevalence of extramedullary myeloma in patients younger than 55 years. Cancer. 2007; 110(4):896-905. DOI: 10.1002/cncr.22850. View

13.

Korbet S, Schwartz M . Multiple myeloma. J Am Soc Nephrol. 2006; 17(9):2533-45. DOI: 10.1681/ASN.2006020139. View

14.

Camp N, Werner T, Cannon-Albright L . Familial myeloma. N Engl J Med. 2008; 359(16):1734-5. DOI: 10.1056/NEJMc081677. View